Search

Home > New FDA Approvals > 018 - FDA approves IV version of Tesaro’s Varubi for CINV; PTC Therapeutics receives complete response letter for Ataluren's NDA; CDC’s ACIP recommends new shingles vaccine over Zostavax; FDA approves first smartphone-ready insertable car
Podcast: New FDA Approvals
Episode:

018 - FDA approves IV version of Tesaro’s Varubi for CINV; PTC Therapeutics receives complete response letter for Ataluren's NDA; CDC’s ACIP recommends new shingles vaccine over Zostavax; FDA approves first smartphone-ready insertable car
Category: Science & Medicine
Duration: 0
Publish Date: 2017-10-26 06:00:00
Description:

10/26/17

0:25 FDA approves intravenous version of Tesaro drug for chemotherapy nausea https://www.reuters.com/article/us-tesaro-fda/fda-approves-intravenous-version-of-tesaro-drug-for-chemotherapy-nausea-idUSKBN1CU3BL

http://ir.tesarobio.com/news-releases/news-release-details/tesaro-announces-us-fda-approval-varubir-iv-delayed-nausea-and

3:04  PTC Therapeutics Receives Complete Response Letter for Ataluren's NDA http://ir.ptcbio.com/releasedetail.cfm?ReleaseID=1045384 

5:15 ACIP recommends new shingles vaccine over Zostavax https://mail.google.com/mail/u/0/#label/Captio/15f57e153e776d94 

7:33 FDA Approves First Smartphone-Ready Insertable Cardiac Monitor  http://abbott.mediaroom.com/2017-10-23-Abbott-Launches-the-First-and-Only-Smartphone-Compatible-Insertable-Cardiac-Monitor-in-the-U-S

Does your company need help with medical writing? Please reach out to us at info@nascentmc.com.
Total Play: 0